PDF(Pubmed)
Abstract：
UNASSIGNED: Severe acute respiratory tract infections (SARI) pose a health threat to children and adults worldwide. The SARI surveillance program was initiated in 2018 in Bahrain to monitor the activity of respiratory pathogens. Salmaniya Medical Complex (SMC) was chosen as the sentinel site for the SARI surveillance program. This study aimed to describe the epidemiology of SARI patients admitted to SMC from 2018 to 2022.
UNASSIGNED: Patients meeting the World Health Organization definition of SARI and presenting with cough and fever within the last 10 days and admitted to SMC from January 2018 until December 2022 were included in the study. Epidemiological data on SARI cases were collected from SARI surveillance data and analyzed using SPSS version 25 and Excel.
UNASSIGNED: A total of 1362 SARI cases were enrolled from January 2018 to the end of December 2022; the majority were males (57.7%, n = 786). The highest SARI incidence rates were recorded among individuals over 65 years old (155.5 per 100,000) in 2021 and among those under 5 years old (887 per 100,000) in 2020. About half of the patients had at least one comorbidity (54.0%, n = 735), with diabetes (23.0%, n = 313) and hypertension (17.2%, n = 234) being the most common. The highest number of cases was observed in 2021 (27%, n = 373), followed by 2018 (20%, n = 267). A viral pathogen was detected in 30.7% (n = 418) of the SARI patients. The most prevalent pathogen was influenza A (11.5%, n = 156), followed by SARS-CoV-2 (9.7%, n = 132), respiratory syncytial virus (RSV) (5.1%, n = 69), and influenza B (3.9%, n = 53). The highest percentage of SARI cases was recorded in the winter months, mainly January (17%, n = 236). The percentages of influenza A and RSV cases were highest in December, at 22% (n = 39) and 14% (n = 25), respectively. Influenza B cases were recorded predominantly in March (9%, n = 11).
UNASSIGNED: The incidence of SARI was highest among patients above 65 years old. The majority had comorbidities. Influenza and respiratory syncytial viruses were the most frequent causes of SARI, with influenza A being the most prevalent. December and January were the months with the highest SARI cases and viral detection rates. Promoting vaccination, timely testing, and prompt treatment, especially for the elderly and those with comorbidities, is key to reducing SARI-related morbidity and mortality, especially during peak seasons.
UNASSIGNED: Patients meeting the World Health Organization definition of SARI and presenting with cough and fever within the last 10 days and admitted to SMC from January 2018 until December 2022 were included in the study. Epidemiological data on SARI cases were collected from SARI surveillance data and analyzed using SPSS version 25 and Excel.
UNASSIGNED: A total of 1362 SARI cases were enrolled from January 2018 to the end of December 2022; the majority were males (57.7%, n = 786). The highest SARI incidence rates were recorded among individuals over 65 years old (155.5 per 100,000) in 2021 and among those under 5 years old (887 per 100,000) in 2020. About half of the patients had at least one comorbidity (54.0%, n = 735), with diabetes (23.0%, n = 313) and hypertension (17.2%, n = 234) being the most common. The highest number of cases was observed in 2021 (27%, n = 373), followed by 2018 (20%, n = 267). A viral pathogen was detected in 30.7% (n = 418) of the SARI patients. The most prevalent pathogen was influenza A (11.5%, n = 156), followed by SARS-CoV-2 (9.7%, n = 132), respiratory syncytial virus (RSV) (5.1%, n = 69), and influenza B (3.9%, n = 53). The highest percentage of SARI cases was recorded in the winter months, mainly January (17%, n = 236). The percentages of influenza A and RSV cases were highest in December, at 22% (n = 39) and 14% (n = 25), respectively. Influenza B cases were recorded predominantly in March (9%, n = 11).
UNASSIGNED: The incidence of SARI was highest among patients above 65 years old. The majority had comorbidities. Influenza and respiratory syncytial viruses were the most frequent causes of SARI, with influenza A being the most prevalent. December and January were the months with the highest SARI cases and viral detection rates. Promoting vaccination, timely testing, and prompt treatment, especially for the elderly and those with comorbidities, is key to reducing SARI-related morbidity and mortality, especially during peak seasons.
摘要：
严重急性呼吸道感染(SARI)对全世界儿童和成人构成健康威胁。SARI监测计划于2018年在巴林启动，以监测呼吸道病原体的活动。Salmaniya医疗综合体（SMC）被选为SARI监视计划的前哨站点。这项研究旨在描述2018年至2022年SMC收治的SARI患者的流行病学。
■符合世界卫生组织定义的SARI并在过去10天内出现咳嗽和发烧并从2018年1月至2022年12月入院SMC的患者被纳入研究。从SARI监测数据中收集SARI病例的流行病学数据，并使用SPSS版本25和Excel进行分析。
■从2018年1月到2022年12月底，共登记了1362例SARI病例；大多数是男性（57.7％，n=786）。SARI发病率最高的是在2021年65岁以上的人群（每10万人中有155.5人）和2020年5岁以下的人群（每10万人中有887人）。大约一半的患者至少有一种合并症（54.0％，n=735),患有糖尿病（23.0%，n=313）和高血压（17.2%，n=234）是最常见的。病例数量最多的是2021年(27%，n=373)，其次是2018年（20%，n=267)。在30.7％（n=418）的SARI患者中检测到病毒病原体。最流行的病原体是甲型流感(11.5%，n=156)，其次是SARS-CoV-2（9.7%，n=132),呼吸道合胞病毒（RSV）（5.1％，n=69)，和乙型流感(3.9%,n=53）。SARI病例的最高百分比是在冬季，主要是1月(17%，n=236)。甲型流感和RSV病例的百分比在12月份最高,22%(n=39)和14%(n=25)，分别。乙型流感病例主要记录在3月(9%，n=11）。
■SARI的发生率在65岁以上的患者中最高。大多数有合并症。流感和呼吸道合胞病毒是SARI的最常见原因，甲型流感是最普遍的。12月和1月是SARI病例和病毒检测率最高的月份。促进疫苗接种，及时测试,及时治疗，特别是对于老年人和有合并症的人，是降低SARI相关发病率和死亡率的关键，尤其是在旺季。
■符合世界卫生组织定义的SARI并在过去10天内出现咳嗽和发烧并从2018年1月至2022年12月入院SMC的患者被纳入研究。从SARI监测数据中收集SARI病例的流行病学数据，并使用SPSS版本25和Excel进行分析。
■从2018年1月到2022年12月底，共登记了1362例SARI病例；大多数是男性（57.7％，n=786）。SARI发病率最高的是在2021年65岁以上的人群（每10万人中有155.5人）和2020年5岁以下的人群（每10万人中有887人）。大约一半的患者至少有一种合并症（54.0％，n=735),患有糖尿病（23.0%，n=313）和高血压（17.2%，n=234）是最常见的。病例数量最多的是2021年(27%，n=373)，其次是2018年（20%，n=267)。在30.7％（n=418）的SARI患者中检测到病毒病原体。最流行的病原体是甲型流感(11.5%，n=156)，其次是SARS-CoV-2（9.7%，n=132),呼吸道合胞病毒（RSV）（5.1％，n=69)，和乙型流感(3.9%,n=53）。SARI病例的最高百分比是在冬季，主要是1月(17%，n=236)。甲型流感和RSV病例的百分比在12月份最高,22%(n=39)和14%(n=25)，分别。乙型流感病例主要记录在3月(9%，n=11）。
■SARI的发生率在65岁以上的患者中最高。大多数有合并症。流感和呼吸道合胞病毒是SARI的最常见原因，甲型流感是最普遍的。12月和1月是SARI病例和病毒检测率最高的月份。促进疫苗接种，及时测试,及时治疗，特别是对于老年人和有合并症的人，是降低SARI相关发病率和死亡率的关键，尤其是在旺季。
